Niagen Bioscience, Inc. (NAGE) vs Cartesian Therapeutics, Inc. (RNAC)
- Niagen Bioscience, Inc. NAGE 2.49 −3.49%
- Cartesian Therapeutics, Inc. RNAC 6.27 −4.71%
Niagen Bioscience, Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Cartesian Therapeutics, Inc. are of similar size ($204.2M and $199.1M). Cartesian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −94.8%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 13 and Cartesian Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | NAGE | RNAC | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | 100.00% | 65.16% |
| Operating margin | 8.21% | 0.00% | 0.00% |
| Net margin | 12.39% | 0.00% | 0.00% |
| Free cash flow margin | 8.89% | 0.00% | 0.00% |
| Return on equity | 21.80% | 236.88% | (56.36%) |
| Return on assets | 16.14% | (42.77%) | (48.04%) |
| Return on invested capital | 41.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack